![PDF) session D: miscellanea D38 FOTEMUSTINE AS RESCUE THERAPY IN RECURRENT OR PROGRESSIVE GLIOBLASTOMA AFTER FIRST-LINE TEMOZOLOMIDE CHEMOTHERAPY PDF) session D: miscellanea D38 FOTEMUSTINE AS RESCUE THERAPY IN RECURRENT OR PROGRESSIVE GLIOBLASTOMA AFTER FIRST-LINE TEMOZOLOMIDE CHEMOTHERAPY](https://i1.rgstatic.net/publication/253233596_session_D_miscellanea_D38_FOTEMUSTINE_AS_RESCUE_THERAPY_IN_RECURRENT_OR_PROGRESSIVE_GLIOBLASTOMA_AFTER_FIRST-LINE_TEMOZOLOMIDE_CHEMOTHERAPY/links/0deec51f63eed4db5c000000/largepreview.png)
PDF) session D: miscellanea D38 FOTEMUSTINE AS RESCUE THERAPY IN RECURRENT OR PROGRESSIVE GLIOBLASTOMA AFTER FIRST-LINE TEMOZOLOMIDE CHEMOTHERAPY
![PDF) Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial PDF) Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial](https://i1.rgstatic.net/publication/355567732_Correction_to_Tocilizumab_for_patients_with_COVID-19_pneumonia_The_single-arm_TOCIVID-19_prospective_trial/links/6176fd26a767a03c14b1c45f/largepreview.png)
PDF) Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial
![Giovanna BLANDINO | Full Professor | University of Catania, Catania | UNICT | Department of Biomedical Sciences (BIOMED) Giovanna BLANDINO | Full Professor | University of Catania, Catania | UNICT | Department of Biomedical Sciences (BIOMED)](https://i1.rgstatic.net/ii/profile.image/272483538436113-1441976546833_Q512/Giovanna-Blandino.jpg)